We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antibodies in Drug Discovery: Identifying Novel Biomarkers to Overcome Sjögren’s Syndrome

Article   Aug 02, 2017 | by Dr. Petra Budde, Head of Medical Research, Protagen and Dr Peter Schulz-Knappe, Chief Scientific Officer, Protagen.

 
Antibodies in Drug Discovery: Identifying Novel Biomarkers to Overcome Sjögren’s Syndrome
 
 
 

RELATED ARTICLES

Using Therapeutic Antibodies Against Alzheimer’s Disease

Article

What if immunotherapy was the solution to cure Alzheimer’s disease (AD)? AD represents a major health issue as it affects an increasing number of people each year. The search for a therapy against AD is uncertain. Nevertheless, we can hope that the fast-growing advances in biotechnologies could lead to an improvement in diagnostics and a better understanding of the disease.

READ MORE

Three Ways to Turn Life Science Suppliers into Partners

Article

A growing number of life science businesses are turning to greater supply chain collaboration for benefits like accelerated time to market, improved quality, reduced risk and more rapid and widespread innovation. But while 68% of executives in this industry say active and meaningful engagement with suppliers is essential to success, far too many, over a third, struggle to implement it.

READ MORE

Advanced Data Analytics in Pharma: Going Beyond Patterns to Understand the “Why”

Article

Developments in pharmaceuticals have made new treatments available, enhancing quality of life for patients. Advanced data analytics solutions mean treatments are more effective and affordable, and less intrusive. However, these evolutions will mean major changes in how companies function requiring new capabilities for operations and supply chain.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE